NCT01035333已完成4 期
A Pilot Study of the Efficacy of Alli in the Management of Pre-operative Weight Loss Required for Bariatric Surgery.
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 19
- 试验地点
- 1
- 主要终点
- Weight Loss
研究概览
简要总结
The primary goal of the study is to determine if orlistat 60mg (Alli) is effective in helping patients achieve a required 10% weight loss goal prior to bariatric surgery. The medication will be added to the usual standard of care which includes education regarding diet and exercise and monthly meetings with a registered dietician.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •adult patients preparing for gastric bypass surgery
排除标准
- •pregnancy
研究组 & 干预措施
orlistat 60mg
Experimental
Patients assigned to treatment group for up to 6 months of therapy.
干预措施: Orlistat (Drug)
结局指标
主要结局
Weight Loss
时间窗: 6 months
Weight loss acheived during time on study up to 6 months.
次要结局
- Patient Satisfaction(6 months)
研究者
Margaret Malone
Dr
Albany College of Pharmacy and Health Sciences
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
3 期
Study of Efficacy of Different Treatment Regimens of OlokizumabCOVID-19NCT05187793R-Pharm198
进行中（未招募）
不适用
Mycosis Culture Collection From Dermatological IsolatedResistant InfectionNail DiseasesOnychomycosisNCT05482763University of Rome Tor Vergata200
尚未招募
4 期
The Possible Efficacy and Protective Effect of Empagliflozin in Rheumatoid Arthritis Patients Treated with MethotrexateRheumatoid Arthritis (RA)Methotrexate Induced NephrotoxicityMethotrexate Adverse ReactionNCT06641128Tanta University44
已完成
4 期
Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia (CCCA)Central Centrifugal Cicatricial AlopeciaNCT03521687Icahn School of Medicine at Mount Sinai20
Unknown
2 期
Isotretinoin In Preventing Recurrences In Chronic Recurrent DermatophytosisTineaNCT03471455Post Graduate Institute of Medical Education and Research, Chandigarh100